By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



11095 Flintkote Avenue
Suite D
San Diego  California  92121  U.S.A.
Phone: Fax:



Company News
Ignyta (RXDX) Announces The Release For Clinical Use Of A Proprietary NGS Clinical Trial Assay To Support Its STARTRK Clinical Studies 6/30/2015 1:20:32 PM
Ignyta (RXDX) Added To Russell 2000 Index 6/30/2015 12:04:35 PM
Ignyta (RXDX) Announces Proposed Public Offering Of $75 Million Of Common Stock 6/10/2015 12:20:34 PM
Ignyta (RXDX) Announces Phase 1 Clinical Trial Data For Entrectinib 6/1/2015 11:09:34 AM
Ignyta (RXDX) To Present At 2015 Jefferies and Co. Healthcare Conference 5/28/2015 8:26:21 AM
Ignyta (RXDX) Announces Two Entrectinib Phase I Data Presentations And Webcast Management Presentation At The 2015 ASCO Annual Meeting 5/20/2015 12:03:52 PM
Ignyta (RXDX) Announces First Quarter 2015 Company Highlights And Financial Results 5/12/2015 10:52:10 AM
Ignyta (RXDX) To Report 2015 First Quarter Company Highlights And Financial Results And Host Conference Call On May 11, 2015 5/5/2015 10:59:47 AM
Ignyta (RXDX) Announces Multiple Presentations At The 2015 AACR Annual Meeting 4/20/2015 11:23:37 AM
Ignyta (RXDX) Announces 2014 Full Year Company Highlights And Financial Results 3/18/2015 10:07:09 AM